低剂量辐射疗法动员抗瘤免疫力:新发现和未来的前景
Laiyan Zhou1,2, Yuanxin Liu1, Yuanjun Wu1
1Division of Thoracic Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
International journal of cancer
|December 7, 2023
概括
低剂量辐射疗法 (LDRT) 重塑瘤免疫微环境 (TIME),以增强抗瘤免疫反应. 这一审查涵盖了LDRT.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 辐射疗法 辐射疗法
背景情况:
- 高剂量放射治疗可以产生全身抗瘤效应,但在照射单个病变时,腹膜效应很少见.
- 低剂量辐射疗法 (LDRT) 正成为调节瘤免疫微环境 (TIME) 的新策略.
研究的目的:
- 审查LDRT对TIME和全身瘤免疫力的免疫调节作用.
- 概述LDRT应用的临床前和临床证据.
- 讨论LDRT作为组合治疗的挑战和未来方向.
主要方法:
- 审查临床前研究和临床应用LDRT.
- 分析LDRT在重塑瘤免疫微环境中的作用.
- 讨论LDRT的最佳剂量,分量和药物组合.
主要成果:
- 通过修改时间,LDRT显示了增强抗瘤免疫反应的潜力.
- 临床前和临床数据表明,LDRT可以放大全身抗瘤免疫力.
- LDRT为治疗多转移性疾病提供了低毒性方法.
结论:
- 低激活激活治疗是一种有希望的方法来增强抗瘤免疫力,特别是在多元转移的环境中.
- 需要进一步的研究来优化LDRT协议及其与其他疗法的结合.
- LDRT与其他学科的交叉可能会导致新的综合模式治疗.
相关概念视频
01:27Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K